These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 20724320)

  • 1. Review of Duchenne muscular dystrophy (DMD) for the pediatricians in the community.
    Verma S; Anziska Y; Cracco J
    Clin Pediatr (Phila); 2010 Nov; 49(11):1011-7. PubMed ID: 20724320
    [No Abstract]   [Full Text] [Related]  

  • 2. Valley sign in Becker muscular dystrophy and outliers of Duchenne and Becker muscular dystrophy.
    Pradhan S
    Neurol India; 2004 Jun; 52(2):203-5. PubMed ID: 15269471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Update on the management of Duchenne muscular dystrophy.
    Manzur AY; Kinali M; Muntoni F
    Arch Dis Child; 2008 Nov; 93(11):986-90. PubMed ID: 18667451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Duchenne muscular dystrophy: a 30-year population-based incidence study.
    Dooley J; Gordon KE; Dodds L; MacSween J
    Clin Pediatr (Phila); 2010 Feb; 49(2):177-9. PubMed ID: 20080524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LGMD2I presenting with a characteristic Duchenne or Becker muscular dystrophy phenotype.
    Schwartz M; Hertz JM; Sveen ML; Vissing J
    Neurology; 2005 May; 64(9):1635-7. PubMed ID: 15883334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Missed opportunities for duchenne muscular dystrophy.
    Kaufmann P
    J Pediatr; 2009 Sep; 155(3):309-10. PubMed ID: 19732575
    [No Abstract]   [Full Text] [Related]  

  • 7. [Guidelines of National Consultant in the issue of cardiologic care of patients with Duchenne's and Becker's muscular dystrophy and cardiomyopathy prevention in woman with DMD/BMD mutations (mothers and sisters of patients with dystrophies].
    Sinkiewicz W; Droźdź J; Dubiel JS; Filipiak KJ; Rozentryt P; Wierzchowiecki M; Opolski G
    Kardiol Pol; 2007 Feb; 65(2):223-28. PubMed ID: 17563944
    [No Abstract]   [Full Text] [Related]  

  • 8. Duchenne and Becker muscular dystrophy: from gene diagnosis to molecular therapy.
    Matsuo M
    IUBMB Life; 2002 Mar; 53(3):147-52. PubMed ID: 12102170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CUGC for Duchenne muscular dystrophy (DMD).
    Coote DJ; Davis MR; Cabrera M; Needham M; Laing NG; Nowak KJ
    Eur J Hum Genet; 2018 May; 26(5):749-757. PubMed ID: 29330543
    [No Abstract]   [Full Text] [Related]  

  • 10. Duchenne muscular dystrophy: issues in expanding newborn screening.
    Kemper AR; Wake MA
    Curr Opin Pediatr; 2007 Dec; 19(6):700-4. PubMed ID: 18025940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Changes of serum creatine kinase levels in children with Duchenne muscular dystrophy].
    Sun SC; Peng YS; He JB
    Zhongguo Dang Dai Er Ke Za Zhi; 2008 Feb; 10(1):35-7. PubMed ID: 18289468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early symptoms of Duchenne muscular dystrophy--description of cases of an 18-month-old and an 8-year-old patient.
    Iwańczak F; Stawarski A; Potyrała M; Siedlecka-Dawidko J; Agrawal GS
    Med Sci Monit; 2000; 6(3):592-5. PubMed ID: 11208376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management.
    Bushby K; Finkel R; Birnkrant DJ; Case LE; Clemens PR; Cripe L; Kaul A; Kinnett K; McDonald C; Pandya S; Poysky J; Shapiro F; Tomezsko J; Constantin C;
    Lancet Neurol; 2010 Jan; 9(1):77-93. PubMed ID: 19945913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Global voices of science. When science is not enough: fighting genetic disease in Brazil.
    Zatz M
    Science; 2005 Apr; 308(5718):55-7. PubMed ID: 15802588
    [No Abstract]   [Full Text] [Related]  

  • 15. Continued need for caution in the diagnosis of Duchenne muscular dystrophy.
    Griggs RC; Bushby K
    Neurology; 2005 May; 64(9):1498-9. PubMed ID: 15883307
    [No Abstract]   [Full Text] [Related]  

  • 16. Development of therapy for Duchenne muscular dystrophy.
    Zhang S; Xie H; Zhou G; Yang Z
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2007 Feb; 21(2):194-203. PubMed ID: 17357471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative study of care practices for young boys with Duchenne muscular dystrophy between Japan and European countries: Implications of early diagnosis.
    Takeuchi F; Komaki H; Yamagata Z; Maruo K; Rodger S; Kirschner J; Kubota T; Kimura E; Takeda S; Gramsch K; Vry J; Bushby K; Lochmüller H; Wada K; Nakamura H
    Neuromuscul Disord; 2017 Oct; 27(10):894-904. PubMed ID: 28807665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapy of Duchenne muscular dystrophy with umbilical cord blood stem cell transplantation].
    Zhang C; Feng HY; Huang SL; Fang JP; Xiao LL; Yao XL; Chen C; Ye X; Zeng Y; Lu XL; Wen JM; Zhang WX; Li Z; Feng SW; Xu HG; Huang K; Zhou DH; Chen W; Xie YM; Xi J; Zhang M; Li Y; Liu Y
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Aug; 22(4):399-405. PubMed ID: 16086277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiomyopathy of Duchenne muscular dystrophy: current understanding and future directions.
    Spurney CF
    Muscle Nerve; 2011 Jul; 44(1):8-19. PubMed ID: 21674516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enigmatic conflict of clinical and molecular diagnosis in Duchenne/Becker muscular dystrophy.
    Dubowitz V
    Neuromuscul Disord; 2006 Dec; 16(12):865-6. PubMed ID: 17118656
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.